Search research articles
Contact Us
Filters
Showing results (121-130 of 539) with videos related to
Page
of 54
Sort By:
Haematologica
|
June 13, 2012
Changes in magnetic resonance imaging before and after autologous stem cell transplantation correlate with response and survival in multiple myeloma
Jens Hillengass, Sofia Ayyaz, Kerstin Kilk, et al.
Haematologica
|
February 16, 2019
Quantitative dynamic <sup>18</sup>F-fluorodeoxyglucose positron emission tomography/computed tomography before autologous stem cell transplantation predicts survival in multiple myeloma
Christos Sachpekidis, Maximilian Merz, Annette Kopp-Schneider, et al.
Experimental Hematology
|
February 15, 2011
Gene expression profile of ADAMs and ADAMTSs metalloproteinases in normal and malignant plasma cells and in the bone marrow environment
Caroline Bret, Dirk Hose, Thierry Reme, et al.
Oncotarget
|
May 10, 2014
A DNA repair pathway score predicts survival in human multiple myeloma: the potential for therapeutic strategy
Alboukadel Kassambara, Claire Gourzones-Dmitriev, Surinder Sahota, et al.
Hematological Oncology
|
January 21, 2023
Cyclophosphamide etoposide dexamethasone as salvage and bridging therapy in relapsed refractory and extramedullary multiple myeloma
Joseph Kauer, Lilli Sophie Sester, Katharina Kriegsmann, et al.
Blood Cancer Journal
|
August 27, 2024
Longitudinal assessment of established risk stratification models in patients with monoclonal gammopathy of undetermined significance
Kosima Zuern, Thomas Hielscher, Annika Werly, et al.
EJNMMI Research
|
October 10, 2021
The prognostic significance of [<sup>18</sup>F]FDG PET/CT in multiple myeloma according to novel interpretation criteria (IMPeTUs)
Christos Sachpekidis, Maximilian Merz, Marc-Steffen Raab, et al.
Haematologica
|
March 26, 2017
Novel recurrent chromosomal aberrations detected in clonal plasma cells of light chain amyloidosis patients show potential adverse prognostic effect: first results from a genome-wide copy number array analysis
Martin Granzow, Ute Hegenbart, Katrin Hinderhofer, et al.
International Journal of Cancer
|
April 10, 2020
B-cell maturation antigen-specific chimeric antigen receptor T cells for multiple myeloma: Clinical experience and future perspectives
Leopold Sellner, Fuli Fan, Nicola Giesen, et al.
British Journal of Haematology
|
February 1, 2006
A systematic review of phase-II trials of thalidomide monotherapy in patients with relapsed or refractory multiple myeloma
Axel Glasmacher, Corinna Hahn, Florian Hoffmann, et al.
Page
of 54
Search research articles
Search
Showing results (121-130 of 539) with videos related to
Sort By:
Page
of 54
Haematologica
|
June 13, 2012
Changes in magnetic resonance imaging before and after autologous stem cell transplantation correlate with response and survival in multiple myeloma
Jens Hillengass, Sofia Ayyaz, Kerstin Kilk, et al.
Haematologica
|
February 16, 2019
Quantitative dynamic <sup>18</sup>F-fluorodeoxyglucose positron emission tomography/computed tomography before autologous stem cell transplantation predicts survival in multiple myeloma
Christos Sachpekidis, Maximilian Merz, Annette Kopp-Schneider, et al.
Experimental Hematology
|
February 15, 2011
Gene expression profile of ADAMs and ADAMTSs metalloproteinases in normal and malignant plasma cells and in the bone marrow environment
Caroline Bret, Dirk Hose, Thierry Reme, et al.
Oncotarget
|
May 10, 2014
A DNA repair pathway score predicts survival in human multiple myeloma: the potential for therapeutic strategy
Alboukadel Kassambara, Claire Gourzones-Dmitriev, Surinder Sahota, et al.
Hematological Oncology
|
January 21, 2023
Cyclophosphamide etoposide dexamethasone as salvage and bridging therapy in relapsed refractory and extramedullary multiple myeloma
Joseph Kauer, Lilli Sophie Sester, Katharina Kriegsmann, et al.
Blood Cancer Journal
|
August 27, 2024
Longitudinal assessment of established risk stratification models in patients with monoclonal gammopathy of undetermined significance
Kosima Zuern, Thomas Hielscher, Annika Werly, et al.
EJNMMI Research
|
October 10, 2021
The prognostic significance of [<sup>18</sup>F]FDG PET/CT in multiple myeloma according to novel interpretation criteria (IMPeTUs)
Christos Sachpekidis, Maximilian Merz, Marc-Steffen Raab, et al.
Haematologica
|
March 26, 2017
Novel recurrent chromosomal aberrations detected in clonal plasma cells of light chain amyloidosis patients show potential adverse prognostic effect: first results from a genome-wide copy number array analysis
Martin Granzow, Ute Hegenbart, Katrin Hinderhofer, et al.
International Journal of Cancer
|
April 10, 2020
B-cell maturation antigen-specific chimeric antigen receptor T cells for multiple myeloma: Clinical experience and future perspectives
Leopold Sellner, Fuli Fan, Nicola Giesen, et al.
British Journal of Haematology
|
February 1, 2006
A systematic review of phase-II trials of thalidomide monotherapy in patients with relapsed or refractory multiple myeloma
Axel Glasmacher, Corinna Hahn, Florian Hoffmann, et al.
Page
of 54